Anti-Infective Agents, Urinary
"Anti-Infective Agents, Urinary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading.
Descriptor ID |
D000892
|
MeSH Number(s) |
D27.505.954.122.237 D27.505.954.613.056
|
Concept/Terms |
Anti-Infective Agents, Urinary- Anti-Infective Agents, Urinary
- Anti Infective Agents, Urinary
- Urinary Antiinfective Agents
- Antiinfective Agents, Urinary
- Agents, Urinary Antiinfective
- Urinary Anti-Infective Agents
- Agents, Urinary Anti-Infective
- Urinary Anti Infective Agents
|
Below are MeSH descriptors whose meaning is more general than "Anti-Infective Agents, Urinary".
Below are MeSH descriptors whose meaning is more specific than "Anti-Infective Agents, Urinary".
This graph shows the total number of publications written about "Anti-Infective Agents, Urinary" by people in this website by year, and whether "Anti-Infective Agents, Urinary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2017 | 2 | 0 | 2 |
2018 | 3 | 1 | 4 |
2019 | 3 | 0 | 3 |
2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Infective Agents, Urinary" by people in Profiles.
-
Legionella pneumonia: increased risk after COVID-19 lockdown? Italy, May to June 2020. Euro Surveill. 2020 07; 25(30).
-
In vitro activity of mecillinam and nitroxoline against Neisseria gonorrhoeae - re-purposing old antibiotics in the multi-drug resistance era. J Med Microbiol. 2019 Jul; 68(7):991-995.
-
Safety and efficacy of methenamine hippurate for the prevention of recurrent urinary tract infections in adult renal transplant recipients: A single center, retrospective study. Transpl Infect Dis. 2019 Jun; 21(3):e13063.
-
Single-dose versus 3-day cotrimoxazole prophylaxis in transurethral resection or greenlight laser vaporisation of the prostate: study protocol for a multicentre randomised placebo controlled non-inferiority trial (CITrUS trial). Trials. 2019 Feb 19; 20(1):142.
-
Risk of adverse outcomes following urinary tract infection in older people with renal impairment: Retrospective cohort study using linked health record data. PLoS Med. 2018 09; 15(9):e1002652.
-
Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA. 2018 05 01; 319(17):1781-1789.
-
Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study. BMJ. 2018 02 09; 360:k341.
-
Persistent and severe hypoglycemia associated with trimethoprim-sulfamethoxazole in a frail diabetic man on polypharmacy: A case report and literature review?. Int J Clin Pharmacol Ther. 2018 Feb; 56(2):86-89.
-
Nitroxoline in geriatric patients with lower urinary tract infection fails to achieve microbiologic eradication: a noncomparative, prospective observational study. Clin Microbiol Infect. 2018 04; 24(4):434-435.
-
Empirical treatment of lower urinary tract infections in the face of spreading multidrug resistance: in vitro study on the effectiveness of nitroxoline. Int J Antimicrob Agents. 2018 Feb; 51(2):213-220.